Skip to Main Content

Rebecca L. Olin

MD MSCE

Hematologist

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells).

In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant.

Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania.

  • Education

    Perelman School of Medicine, 2003

    University of Pennsylvania, MS, Clinical Epidemiology , 2009

  • Residencies

    Hospital of the University of Pennsylvania, Internal Medicine, 2006

  • Fellowships

    Hospital of the University of Pennsylvania, Hematology-Oncology, 2009

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

  • Languages

    French

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    152 Ratings
    Explained things in a way that was easy to understand
    150 Ratings
    Did the doctor pay attention to your concerns
    150 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    149 Ratings
    Knew the important information about your medical history
    152 Ratings
    The provider showed respect for what you had to say
    151 Ratings
    The provider spent enough time with me
    151 Ratings
    Decorative Caduceus

    Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

    The feasibility of completing molecular, genetic, immunophenotypic, and biochemical testing for assignment of therapy will be assessed based on the proportion of patients for whom testing is completed within 7 days of the registra...

    Recruiting

    Share